2022
DOI: 10.3390/diagnostics12071748
|View full text |Cite
|
Sign up to set email alerts
|

Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment

Abstract: Background: A new nationwide screening strategy was implemented in Germany in January 2020. No data are available for women referred to certified dysplasia units for secondary clarification after primary diagnosis by a local physician. We therefore investigated combined testing with Papanicolaou smears and high-risk human papillomavirus (hrHPV) and compared the data with the final histological findings. Methods: Between January 2015 and October 2020, all referred women who underwent colposcopy of the uterine c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
13
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(16 citation statements)
references
References 36 publications
1
13
0
2
Order By: Relevance
“…The etiological role of HPV in the development of anogenital carcinomas has been widely studied and is well known [ 13 , 14 ]. However, the role of this virus in the development of non-small cell lung cancer is controversial and is currently under discussion.…”
Section: Discussionmentioning
confidence: 99%
“…The etiological role of HPV in the development of anogenital carcinomas has been widely studied and is well known [ 13 , 14 ]. However, the role of this virus in the development of non-small cell lung cancer is controversial and is currently under discussion.…”
Section: Discussionmentioning
confidence: 99%
“…A new organized screening program was implemented in Germany in January 2020 [ 13 ]. Women between 20 and 34 years of age are continuing to have annual Pap smears, while women over the age of 34 receive a co-test comprising a Pap smear in combination with an hrHPV test every 3 years.…”
Section: Discussionmentioning
confidence: 99%
“…Women between 20 and 34 years of age are continuing to have annual Pap smears, while women over the age of 34 receive a co-test comprising a Pap smear in combination with an hrHPV test every 3 years. All women aged 20–65 are invited for testing by their health insurance providers every 5 years [ 13 , 31 , 32 , 33 , 34 , 35 , 36 ]. We therefore investigated the differences between the two different age groups.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Bacterial and viral pelvic infections are significant diseases among young and adult females; they affect the female reproductive organs, including the vagina, cervix, womb, fallopian tubes, and ovaries. HPV is the most common viral infection of the reproductive tract and a leading sexually transmitted infection worldwide [ 16 , 17 ]. The vascular resistance (PI, RI) of the uterine arteries, ovarian arteries, and tubo-uterine arteries was low at the beginning of the acute phase of pelvic infection [ 18 , 19 , 20 ].…”
Section: Discussionmentioning
confidence: 99%